Diane J. Kalina
President bij BioCatalyst Yorkton, Inc.
Profiel
Ms. Diane J.
Kalina is a Managing Director at PDC Biotech GmbH and President & Director at BioCatalyst Yorkton, Inc. She is on the Board of Directors at BioCatalyst Yorkton, Inc.
Ms. Kalina was previously employed as Head-Marketing, Director-New Products & Licensing by GSK Products, Inc., Chief Financial Officer by Mexigold Corp., and President & Director by YM BioSciences, Inc. She also served on the board at Arius Research, Inc.
Actieve functies van Diane J. Kalina
| Bedrijven | Functie | Begin |
|---|---|---|
| BioCatalyst Yorkton, Inc. | President | 01-01-2005 |
Eerdere bekende functies van Diane J. Kalina
| Bedrijven | Functie | Einde |
|---|---|---|
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Directeur/Bestuurslid | 06-12-2007 |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | President | - |
GSK Products, Inc.
 GSK Products, Inc. Wholesale DistributorsDistribution Services Part of Princeton American Corp., GSK Products, Inc. is a beauty and barber supply concern. The company is based in Phoenix, AZ. | Verkoop & Marketing | - |
PDC Biotech GmbH
 PDC Biotech GmbH BiotechnologyHealth Technology PDC Biotech GmbH operates as a biopharmaceutical company developing innovative therapeutics for the treatment of preterm labor and primary dysmenorrheal in women. The firm’s pipeline products include prostaglandin F2a (FP) receptor antagonists, PDC31 a synthetic octapeptide, which is designed to act as an allosteric modulator of the receptor for prostaglandin FP receptor. The company was founded by Patricia Griffin and Diane J. Kalina in May 2008 and is headquartered in Vienna, Austria. | Algemeen Directeur | - |
| E3 LITHIUM LIMITED | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| E3 LITHIUM LIMITED | Process Industries |
| Bedrijven in privébezit | 5 |
|---|---|
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada. | Health Technology |
GSK Products, Inc.
GSK Products, Inc. Wholesale DistributorsDistribution Services Part of Princeton American Corp., GSK Products, Inc. is a beauty and barber supply concern. The company is based in Phoenix, AZ. | Distribution Services |
| BioCatalyst Yorkton, Inc. | |
PDC Biotech GmbH
PDC Biotech GmbH BiotechnologyHealth Technology PDC Biotech GmbH operates as a biopharmaceutical company developing innovative therapeutics for the treatment of preterm labor and primary dysmenorrheal in women. The firm’s pipeline products include prostaglandin F2a (FP) receptor antagonists, PDC31 a synthetic octapeptide, which is designed to act as an allosteric modulator of the receptor for prostaglandin FP receptor. The company was founded by Patricia Griffin and Diane J. Kalina in May 2008 and is headquartered in Vienna, Austria. | Health Technology |
